Related Experiment Video
Updated: Jun 3, 2025
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
16.1K
BNIP3 Downregulation Ameliorates Muscle Atrophy in Cancer Cachexia
Claudia Fornelli1, Marc Beltrà2, Antonio Zorzano2
1Department of Clinical and Biological Sciences, University of Torino, 10043 Turin, Italy.
Cancers
|January 8, 2025
Summary
Downregulating BNIP3 partially prevents cancer-induced muscle atrophy by improving mitochondrial integrity. This suggests BNIP3 modulation may combat cancer cachexia and muscle wasting.
Area of Science:
- Mitochondrial biology
- Cancer research
- Muscle physiology
Background:
- Cancer cachexia causes significant mortality, characterized by muscle wasting due to excessive protein breakdown and mitophagy.
- BNIP3, a key mitophagy regulator, is elevated in cancer hosts, contributing to muscle loss.
- Excessive mitophagy disrupts muscle mass, quality, and function.
Purpose of the Study:
- To investigate the potential of mitigating mitophagy by downregulating BNIP3.
- To assess the impact of BNIP3 downregulation on mitochondrial integrity and skeletal muscle mass in experimental cancer cachexia.
Main Methods:
- Adenovirus-mediated gene delivery was used to achieve muscle-specific BNIP3 knockdown in tumor-bearing mice.
- Muscle fiber size, mitochondrial respiratory chain complex levels, and oxidative balance were analyzed.
Main Results:
- Adenovirus-mediated BNIP3 knockdown reduced BNIP3 levels in tumor hosts.
- BNIP3 knockdown did not affect overall body or muscle mass but improved muscle fiber size, indicating partial prevention of atrophy.
- Mitochondrial mass and respiratory function were improved, with no adverse effects on oxidative balance.
Conclusions:
- A balance between mitochondrial disposal and biogenesis is crucial for muscle homeostasis.
- Modulating BNIP3 presents a potential therapeutic strategy against cancer-induced muscle wasting.
